Wampole Laboratories
Industry
- In Vitro Diagnostics
- Chemistry, Immunoassay
- Biotechnology
Latest on Wampole Laboratories
Device Transactions Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. ( See Exhibit 1. ) Late-stage venture capital rounds represented most of
In Vitro Diagnostics Acquisitions Beckman Coulter Inc. Lumigen Inc. Beckman Coulter has acquired Lumigen (chemiluminescent detection technologies) for $185mm. (Oct.) The deal, expected to close ne
In Vitro Diagnostics Acquisitions Inverness Medical Innovations Inc. Acon Laboratories Inc. Resolving all previous patent litigation, immunodiagnostics company Inverness Medical Innovations has acqu
Born of a leveraged buy-out, MedPointe is subject to financial restraints that demand focus on earnings. Beyond competing with far bigger pharma marketers, management's key challenge remains bringing